Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19

M Zarei, N Sahebi Vaighan, SA Ziai - Immunopharmacology and …, 2021 - Taylor & Francis
… Many therapeutic agents administered in COVID-19 have … most administered drug in the
therapy of COVID-19. Anakinra, … as immunomodulatory drugs to treat COVID-19 so far [Citation…

Therapeutic management of COVID-19 patients: Clinical manifestation and limitations

U Fatima, SSA Rizvi, N Raina, S Fatima… - Current …, 2021 - ingentaconnect.com
COVID-19 treatment. In this review, we have attempted to discuss various therapeutic approaches
to handle COVID-19… and Tocilizumab) for COVID-19 patients with an emphasis on CQ …

A review on remdesivir: a possible promising agent for the treatment of COVID-19

SMR Hashemian, T Farhadi… - … , development and therapy, 2020 - Taylor & Francis
… of COVID-19 using remdesivir. In this study, characteristics of remdesivir and its usage for
treatment of COVID-19 are … as a prophylactic and therapeutic agent against MERS. Citation…

[HTML][HTML] Emerging therapeutics in the management of COVID-19

A Kichloo, M Albosta, A Kumar, M Aljadah… - World Journal of …, 2021 - ncbi.nlm.nih.gov
coronavirus disease 2019 continues to affect the global community, researchers are working
diligently to determine the efficacy of therapeutic agents … all of the therapeutic agents under …

Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID19

PM Heister, RN Poston - Pharmacology research & …, 2020 - Wiley Online Library
… affected by agents that interact with P450 enzymes. This applies to therapeutic agents as well
agents such as ritonavir. This is of particular relevance in this context, as in the treatment of …

Screening of therapeutic agents for COVID-19 using machine learning and ensemble docking studies

R Batra, H Chan, G Kamath, R Ramprasad… - The journal of …, 2020 - ACS Publications
… to screen therapeutic molecules … therapeutic agents against COVID-19. Figure 1a presents
the adopted screening workflow, while an illustration of the interface between coronavirus

Therapeutic strategies to fight COVID19: Which is the status artis?

C Scavone, A Mascolo, C Rafaniello… - British Journal of …, 2022 - Wiley Online Library
… Many clinical trials evaluated the efficacy and safety of hydroxychloroquine as therapeutic
agent. Gautret et al. carried out a single-arm interventional study, which evaluated the effects …

Harnessing inflammation resolving‐based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID19?

LP Sousa, V Pinho, MM Teixeira - British journal of …, 2020 - Wiley Online Library
… of COVID-19, regulating the host response during the phase of over-exuberant inflammation
and excessive coagulation may offer new therapeutic … strategies in the context of COVID-19. …

The current understanding and potential therapeutic options to combat COVID-19

V Pooladanda, S Thatikonda, C Godugu - Life sciences, 2020 - Elsevier
… respiratory illness is designated as coronavirus disease 19 (COVID-19). The SARS-CoV-2 …
in the COVID-19 pathogenicity. Furthermore, we focused on possible therapeutic options …

[PDF][PDF] A mini-review on the current COVID-19 therapeutic strategies

S Shafiee, S Davaran - Chemical Review and Letters, 2020 - chemrevlett.com
… The care-related procedures for COVID-19 initially include oxygen therapy when is required
… drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. …